A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
Phase 1/2
15
about 2.2 years
18+
2 sites in IL, NY
About this study
This trial is testing a treatment called LP-118 with other medicines like ponatinib, vincristine, and dexamethasone in people whose leukemia has returned after treatment or hasn't responded to previous treatments. The goal is to find out if LP-118 can be used safely along with these other medications.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Dexamethasone
- 2.Take LP-118
- 3.Take Methotrexate
- +2 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
dexamethasone, methotrexate, ponatinib, vincristine
injection, ocular, oral (Oral Tablet)
Secondary: Complete Clinical Remission (CR) with Measurable Residual Disease (MRD), Overall Survival, Progression-Free Survival
Oncology